The Global Market for Hematology Instruments and Reagents is Projected to Reach US$16.4 Billion by the Year 2024
Increase in
Blood Related Disorders, Automation, and High Throughput Analyzers Drive the Global
Hematology Instruments and Reagents Market, According to a New Report by Global Industry Analysts, Inc.
GIA launches comprehensive analysis of industry
segments, trends, growth drivers, market share, size and demand forecasts on
the global Hematology Instruments and Reagents market. The
global market for Hematology Instruments and Reagents is projected to reach US$16.4
billion by the year 2024, driven by rising incidence of
blood-related disorders; automation; and emergence of high-throughput
hematology analyzers. Adoption of advanced technology by labs; rising awareness about bleeding disorders,
stem cell research and genetic therapies represent the other growth drivers.
The global hematology instruments and reagents
market is growing at a rapid rate, driven by growing incidence of blood
disorders, such as anemia, blood cancer, among others, and bleeding disorders
such as blood clots, hemophilia, etc.
Further, rising incidence of kidney diseases is also said to drive the
hematology market. Automation and emergence of high-throughput hematology
analyzers are the key trends driving the market. Adoption of advanced
technology by labs, coupled with the overall advancements in proteomics, rising
awareness about bleeding disorders, pharmacogenomics, molecular biology, stem
cell research, and genetic therapies drive the market for hematology
instruments and reagents. The hematology instruments and reagents market is
also driven by government initiatives to improve healthcare infrastructure,
coupled with the various technological advancements in the field.
Hematology analyzers represent one of the leading
segments in the hematology market, driven by their rising application in
research and for drug development efforts. Among the
developing world, the growing number of blood transfusions and rising awareness
of blood safety are the key factors driving the demand for blood
cell analyzers. Coagulation analyzers are finding increasing adoption
globally owing to increasing incidence of blood disorders and heart diseases,
including atrial fibrillation. The ability of coagulation analyzers to expedite
turnaround time for enabling timely diagnosis of medical condition, especially
in emergency departments, is likely to drive their adoption in both developed
and developing countries. Improved accuracy, timely results, and ease of use
are the key advantages of coagulation analyzers.
As stated by the new market research report on Hematology
Instruments and Reagents, the United States represents the largest market worldwide
supported by the increasing incidence of blood disorders such as anemia and
blood cancer. Asia-Pacific represents the fastest growing market, registering a
CAGR of 10.1% during the analysis period. Growing infusion of private as well
as public capital in emerging markets, such as China and India, is fueling
growth for hematology instruments and reagents in these markets. The in-vitro
diagnostics market of China and India are registering significant growth, owing
to the growing population, economic development, increased healthcare spending,
and higher affordability for private medical care.
Major players in the market include Abbott
Diagnostics Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Drucker
Diagnostics, Horiba Ltd., Instrumentation Laboratory Inc., Shenzhen Mindray
Bio-Medical Electronics Co. Ltd., Roche Diagnostics AG, Siemens Healthcare, Merck
KGaA, Stago, Sysmex Corporation, Sysmex America Inc., and Tcoag Ireland Ltd., among
others.
The research report titled "Hematology
Instruments and Reagents: A Global Strategic Business Report"
announced by Global Industry Analysts, Inc., provides a comprehensive review of
market trends, drivers, and strategic industry activities of major companies
worldwide. The report provides market estimates and projections in US dollars for
all major geographic markets, including the US, Canada, Japan, Europe (France,
Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China,
India and Rest of Asia Pacific), Latin America and Rest of World. The report
also analyzes the global market for Hematology Instruments and Reagents by product
segment - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology
Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers,
Hematology Centrifuges, and Hematology Vials), and Hematology/Coagulation
Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents,
Immuno-Hematology Reagents, Control Plasmas, and Hematology Stains).
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To
connect with us, visit our LinkedIn page.
Comments
Post a Comment